|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bruix J, Reig M and Sherman M:
Evidence-based diagnosis, staging, and treatment of patients with
hepatocellular carcinoma. Gastroenterology. 150:835–853. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chacko S and Samanta S: ‘Hepatocellular
carcinoma: A life-threatening disease’. Biomed Pharmacother.
84:1679–1688. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kanehira M, Harada Y, Takata R, Shuin T,
Miki T, Fujioka T, Nakamura Y and Katagiri T: Involvement of
upregulation of DEPDC1 (DEP domain containing 1) in bladder
carcinogenesis. Oncogene. 26:6448–6455. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kretschmer C, Sterner-Kock A, Siedentopf
F, Schoenegg W, Schlag PM and Kemmner W: Identification of early
molecular markers for breast cancer. Mol Cancer. 10:152011.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Okayama H, Kohno T, Ishii Y, Shimada Y,
Shiraishi K, Iwakawa R, Furuta K, Tsuta K, Shibata T, Yamamoto S,
et al: Identification of genes upregulated in ALK-positive and
EGFR/KRAS/ALK-negative lung adenocarcinomas. Cancer Res.
72:100–111. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yuan SG, Liao WJ, Yang JJ, Huang GJ and
Huang ZQ: DEP domain containing 1 is a novel diagnostic marker and
prognostic predictor for hepatocellular carcinoma. Asian Pac J
Cancer Prev. 15:10917–10922. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Harada Y, Kanehira M, Fujisawa Y, Takata
R, Shuin T, Miki T, Fujioka T, Nakamura Y and Katagiri T:
Cell-permeable peptide DEPDC1-ZNF224 interferes with
transcriptional repression and oncogenicity in bladder cancer
cells. Cancer Res. 70:5829–5839. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ramalho-Carvalho J, Martins JB, Cekaite L,
Sveen A, Torres-Ferreira J, Graça I, Costa-Pinheiro P, Eilertsen
IA, et al: Epigenetic disruption of miR-130a promotes prostate
cancer by targeting SEC23B and DEPDC1. Cancer Lett. 385:150–159.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang Q, Li A, Jin J and Huang G: Targeted
interfering DEP domain containing 1 protein induces apoptosis in
A549 lung adenocarcinoma cells through the NF-κB signaling pathway.
Onco Targets Ther. 10:4443–4454. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wolf BB, Schuler M, Echeverri F and Green
DR: Caspase-3 is the primary activator of apoptotic DNA
fragmentation via DNA fragmentation factor-45/inhibitor of
caspase-activated DNase inactivation. J Biol Chem. 274:30651–30656.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Pacifico F and Leonardi A: NF-kappaB in
solid tumors. Biochem Pharmacol. 72:1142–1152. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Karin M: Nuclear factor-kappaB in cancer
development and progression. Nature. 441:431–436. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kasibhatla S, Brunner T, Genestier L,
Echeverri F, Mahboubi A and Green DR: DNA damaging agents induce
expression of Fas ligand and subsequent apoptosis in T lymphocytes
via the activation of NF-kappa B and AP-1. Mol Cell. 1:543–551.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Meteoglu I, Erdogdu IH, Meydan N, Erkus M
and Barutca S: NF-KappaB expression correlates with apoptosis and
angiogenesis in clear cell renal cell carcinoma tissues. J Exp Clin
Cancer Res. 27:532008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
López-Terrada D, Cheung SW, Finegold MJ
and Knowles BB: Hep G2 is a hepatoblastoma-derived cell line. Hum
Pathol. 40:1512–1515. 2009. View Article : Google Scholar
|
|
18
|
Gu X, Li A, Liu S, Lin L, Xu S, Zhang P,
Li S, Li X, Tian B, Zhu X and Wang X: MicroRNA124 regulated neurite
elongation by targeting OSBP. Mol Neurobiol. 53:6388–6396. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bazzoni F, Rossato M, Fabbri M, Gaudiosi
D, Mirolo M, Mori L, Tamassia N, Mantovani A, Cassatella MA and
Locati M: Induction and regulatory function of miR-9 in human
monocytes and neutrophils exposed to proinflammatory signals. Proc
Natl Acad Sci USA. 106:5282–5287. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ma X, Becker Buscaglia LE, Barker JR and
Li Y: MicroRNAs in NF-kappaB signaling. J Mol Cell Biol. 3:159–166.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Niu J, Shi Y, Tan G, Yang CH, Fan M,
Pfeffer LM and Wu ZH: DNA damage induces NF-κB-dependent
microRNA-21 up-regulation and promotes breast cancer cell invasion.
J Biol Chem. 287:21783–21795. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Scisciani C, Vossio S, Guerrieri F,
Schinzari V, de Iaco R, D'Onorio de Meo P, Cervello M, Montalto G,
Pollicino T, Raimondo G, et al: Transcriptional regulation of
miR-224 upregulated in human HCCs by NFκB inflammatory pathways. J
Hepatol. 56:855–861. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
López-Terrada D, Cheung SW, Finegold MJ
and Knowles BB: Hep G2 is a hepatoblastoma-derived cell line. Hum
Pathol. 40:1512–1515. 2009. View Article : Google Scholar
|
